3043 companies

Enimmune

Market Cap: NT$1.5b

Operates as a biopharmaceutical Research and development, and marketing company in Taiwan.

6564

NT$21.20

7D

2.4%

1Y

-37.6%

Albert David

Market Cap: ₹4.4b

Manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally.

524075

₹782.70

7D

-2.3%

1Y

-45.8%

FullHope BiomedicalLtd

Market Cap: NT$1.5b

Engages in the research and development of immune system-related services.

7773

NT$38.20

7D

-1.4%

1Y

-44.8%

ACC Aviation Holdings

Market Cap: US$49.9m

Focuses on developing canna powder products.

CAVG

US$0.10

7D

0%

1Y

-88.7%

Quratis

Market Cap: ₩69.9b

Engages in developing vaccines in South Korea.

A348080

₩947.00

7D

-5.8%

1Y

4.3%

Navana Pharmaceuticals

Market Cap: ৳6.1b

Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh.

NAVANAPHAR

৳56.50

7D

0.2%

1Y

9.7%

Holy Stone Healthcare

Market Cap: NT$1.5b

Develops and sells hyaluronic acid related therapeutic products.

4194

NT$10.40

7D

2.0%

1Y

-39.9%

FibroGen

Market Cap: US$49.8m

A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.

FGEN

US$12.31

7D

0.7%

1Y

23.3%

Earth Science Tech

Market Cap: US$49.8m

Together with its subsidies, focuses on health and wellness industry.

ETST

US$0.17

7D

-8.1%

1Y

3.0%

Vivoryon Therapeutics

Market Cap: €42.5m

Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.

VVY

€1.62

7D

-3.0%

1Y

-45.9%

Sinil Pharmaceutical

Market Cap: ₩69.6b

Manufactures and sells pharmaceutical products in South Korea and internationally.

A012790

₩6,150.00

7D

-2.4%

1Y

-16.1%

Barinthus Biotherapeutics

Market Cap: US$49.7m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

BRNS

US$1.22

7D

10.4%

1Y

2.5%

Guard Therapeutics International

Market Cap: SEK 461.8m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

GUARD

SEK 22.90

7D

-3.0%

1Y

-18.2%

Sareum Holdings

Market Cap: UK£36.6m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

SAR

UK£0.27

7D

-1.9%

1Y

0%

Jin Yang Pharmaceutical

Market Cap: ₩68.2b

Engages in the pharmaceutical business in South Korea.

A007370

₩5,750.00

7D

-3.4%

1Y

8.3%

iAnthus Capital Holdings

Market Cap: CA$67.8m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

IAN

CA$0.01

7D

0%

1Y

0%

Sona Nanotech

Market Cap: CA$67.7m

Operates as a nanotechnology life sciences company.

SONA

CA$0.60

7D

-1.6%

1Y

122.2%

Ark Solutions

Market Cap: ₩68.9b

Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally.

A203690

₩4,425.00

7D

0%

1Y

-63.6%

GENINUS

Market Cap: ₩67.9b

A bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea.

A389030

₩2,090.00

7D

4.5%

1Y

31.5%

ORIENT BIO

Market Cap: ₩67.8b

Operates in the bio-industry in South Korea.

A002630

₩584.00

7D

-1.4%

1Y

26.1%

Kadimastem

Market Cap: ₪162.3m

A biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases.

KDST

₪34.90

7D

19.2%

1Y

375.9%

Cannabist Company Holdings

Market Cap: US$48.4m

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally.

CBST.F

US$0.097

7D

-11.1%

1Y

-58.7%

Lantern Pharma

Market Cap: US$48.1m

Focuses on the discovery and development of oncology drug.

LTRN

US$4.46

7D

7.1%

1Y

21.4%

Lytix Biopharma

Market Cap: NOK 477.8m

A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.

LYTIX

NOK 7.00

7D

1.4%

1Y

14.4%

PDS Biotechnology

Market Cap: US$48.0m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

PDSB

US$1.02

7D

-5.6%

1Y

-73.3%

TMS

Market Cap: JP¥7.1b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

4891

JP¥158.00

7D

-3.7%

1Y

-17.3%

Yuyu Pharma

Market Cap: ₩66.9b

Develops and markets pharmaceutical products.

A000220

₩4,270.00

7D

-2.0%

1Y

-7.2%

Rafael Holdings

Market Cap: US$47.7m

Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel.

RFL

US$1.36

7D

-9.9%

1Y

-29.9%

Genetics Generation Advancement

Market Cap: NT$1.4b

Provides genetic testing and informatics services in Taiwan.

4160

NT$54.20

7D

1.7%

1Y

-40.8%

Inotiv

Market Cap: US$47.4m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

NOTV

US$1.38

7D

-1.4%

1Y

-18.8%

October PharmaE

Market Cap: ج.م2.3b

Manufactures and sells pharmaceutical products in Egypt.

OCPH

ج.م189.32

7D

1.0%

1Y

54.3%

Kim Forest Enterprise

Market Cap: NT$1.4b

Provides various genetic and medical testing services in China and the United States.

6645

NT$23.60

7D

1.3%

1Y

-17.9%

Telomir Pharmaceuticals

Market Cap: US$47.0m

A preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases.

TELO

US$1.39

7D

-10.9%

1Y

-78.3%

Bafna Pharmaceuticals

Market Cap: ₹4.2b

Manufactures and sells finished pharmaceutical formulations in India.

BAFNAPH

₹172.80

7D

19.1%

1Y

103.3%

EyeGene

Market Cap: ₩65.1b

Engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea.

A185490

₩2,435.00

7D

-6.3%

1Y

-20.0%

Tianda Pharmaceuticals

Market Cap: HK$361.2m

Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.

455

HK$0.17

7D

7.7%

1Y

-19.6%

Page 50 of 85